1. Home
  2. PRME vs GCMG Comparison

PRME vs GCMG Comparison

Compare PRME & GCMG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PRME
  • GCMG
  • Stock Information
  • Founded
  • PRME 2019
  • GCMG 1971
  • Country
  • PRME United States
  • GCMG United States
  • Employees
  • PRME N/A
  • GCMG N/A
  • Industry
  • PRME Medicinal Chemicals and Botanical Products
  • GCMG Finance/Investors Services
  • Sector
  • PRME Health Care
  • GCMG Finance
  • Exchange
  • PRME Nasdaq
  • GCMG Nasdaq
  • Market Cap
  • PRME 693.5M
  • GCMG 611.5M
  • IPO Year
  • PRME 2022
  • GCMG N/A
  • Fundamental
  • Price
  • PRME $5.10
  • GCMG $11.74
  • Analyst Decision
  • PRME Buy
  • GCMG Buy
  • Analyst Count
  • PRME 6
  • GCMG 4
  • Target Price
  • PRME $8.88
  • GCMG $14.88
  • AVG Volume (30 Days)
  • PRME 4.0M
  • GCMG 718.5K
  • Earning Date
  • PRME 11-11-2025
  • GCMG 11-07-2025
  • Dividend Yield
  • PRME N/A
  • GCMG 3.75%
  • EPS Growth
  • PRME N/A
  • GCMG N/A
  • EPS
  • PRME N/A
  • GCMG 0.19
  • Revenue
  • PRME $4,961,000.00
  • GCMG $533,097,999.00
  • Revenue This Year
  • PRME $179.58
  • GCMG $4.88
  • Revenue Next Year
  • PRME N/A
  • GCMG $11.78
  • P/E Ratio
  • PRME N/A
  • GCMG $63.05
  • Revenue Growth
  • PRME 739.42
  • GCMG 15.56
  • 52 Week Low
  • PRME $1.11
  • GCMG $10.91
  • 52 Week High
  • PRME $6.94
  • GCMG $14.48
  • Technical
  • Relative Strength Index (RSI)
  • PRME 46.40
  • GCMG 42.72
  • Support Level
  • PRME $5.39
  • GCMG $11.43
  • Resistance Level
  • PRME $6.30
  • GCMG $11.76
  • Average True Range (ATR)
  • PRME 0.66
  • GCMG 0.18
  • MACD
  • PRME -0.15
  • GCMG 0.02
  • Stochastic Oscillator
  • PRME 1.60
  • GCMG 52.46

About PRME Prime Medicine Inc.

Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.

About GCMG GCM Grosvenor Inc.

GCM Grosvenor Inc is a world-wide alternative asset management firm. It invests on behalf of clients who seek allocations to alternative investments, such as private equity, infrastructure, real estate, credit, ESG and absolute return strategies. Company invest maximum in Private Equity. The company's offerings include multi-manager portfolios as well as portfolios of direct investments and co-investments.

Share on Social Networks: